Chi‐Hsiung Wang

1.6k total citations
69 papers, 1.1k citations indexed

About

Chi‐Hsiung Wang is a scholar working on Surgery, Cancer Research and Genetics. According to data from OpenAlex, Chi‐Hsiung Wang has authored 69 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 19 papers in Cancer Research and 16 papers in Genetics. Recurrent topics in Chi‐Hsiung Wang's work include Breast Cancer Treatment Studies (16 papers), BRCA gene mutations in cancer (13 papers) and Global Cancer Incidence and Screening (9 papers). Chi‐Hsiung Wang is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), BRCA gene mutations in cancer (13 papers) and Global Cancer Incidence and Screening (9 papers). Chi‐Hsiung Wang collaborates with scholars based in United States, Taiwan and China. Chi‐Hsiung Wang's co-authors include Katharine Yao, David J. Winchester, Erik Liederbach, Catherine Pesce, Mark Sisco, Seth B. Krantz, John A. Howington, Gaurav S. Ajmani, Olga Kantor and Waseem Lutfi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Critical Care Medicine.

In The Last Decade

Chi‐Hsiung Wang

66 papers receiving 1.1k citations

Peers

Chi‐Hsiung Wang
Haiyan Liu United States
Tal Sella Israel
Gerald Langman United Kingdom
Ines Buccimazza South Africa
Natasha M. Rueth United States
Chi‐Hsiung Wang
Citations per year, relative to Chi‐Hsiung Wang Chi‐Hsiung Wang (= 1×) peers Balakrishnan Rajan

Countries citing papers authored by Chi‐Hsiung Wang

Since Specialization
Citations

This map shows the geographic impact of Chi‐Hsiung Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Hsiung Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Hsiung Wang more than expected).

Fields of papers citing papers by Chi‐Hsiung Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Hsiung Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Hsiung Wang. The network helps show where Chi‐Hsiung Wang may publish in the future.

Co-authorship network of co-authors of Chi‐Hsiung Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Hsiung Wang. A scholar is included among the top collaborators of Chi‐Hsiung Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Hsiung Wang. Chi‐Hsiung Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuchta, Kristine, Chi‐Hsiung Wang, Katherine Kopkash, et al.. (2023). Rates of newly diagnosed breast cancer at commission on cancer facilities during the early phase of the COVID‐19 pandemic. Cancer Medicine. 13(1). e6874–e6874. 3 indexed citations
2.
Xu, Jianfeng, Zhuqing Shi, Jun Wei, et al.. (2022). KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression. Prostate Cancer and Prostatic Diseases. 25(4). 749–754. 2 indexed citations
3.
Xu, Jianfeng, Zhuqing Shi, Jun Wei, et al.. (2022). Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies. Prostate Cancer and Prostatic Diseases. 25(3). 422–430. 14 indexed citations
4.
Helfand, Brian T., Chi‐Hsiung Wang, Pooja Talaty, et al.. (2022). The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer. PLoS ONE. 17(9). e0273782–e0273782. 7 indexed citations
5.
Xu, Jianfeng, William B. Isaacs, Mufaddal Mamawala, et al.. (2021). Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients. The Prostate. 81(10). 703–709. 9 indexed citations
6.
Shi, Zhuqing, Jun Wei, Chi‐Hsiung Wang, et al.. (2021). Association of Sickle Cell Trait with Risk and Mortality of COVID-19: Results from the United Kingdom Biobank. American Journal of Tropical Medicine and Hygiene. 105(2). 368–371. 9 indexed citations
7.
Chen, Hsin‐Liang, Chi‐Hsiung Wang, & Jen‐Shiun Chiang. (2020). Reconfigurable Double-Sampled Cascaded Sigma-Delta Modulator with Power Minimizing and System Stabilizing Strategy for Multi-Mode Applications. Tamkang University Institutional Repository (TKUIR). 23(4). 643–654.
8.
Yu, Hongjie, Zhuqing Shi, Yishuo Wu, et al.. (2019). Concept and benchmarks for assessing narrow‐sense validity of genetic risk score values. The Prostate. 79(10). 1099–1105. 14 indexed citations
9.
Shi, Zhuqing, Hongjie Yu, Yishuo Wu, et al.. (2018). Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease. Clinical Genetics. 95(2). 302–309. 4 indexed citations
10.
Winchester, David J., et al.. (2018). Differences in the Impact of Age on Mortality in Well-Differentiated Thyroid Cancer. Annals of Surgical Oncology. 25(11). 3193–3199. 15 indexed citations
11.
Ajmani, Gaurav S., Chi‐Hsiung Wang, Ki Wan Kim, John A. Howington, & Seth B. Krantz. (2018). Surgical quality of wedge resection affects overall survival in patients with early stage non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 156(1). 380–391.e2. 28 indexed citations
12.
Krantz, Seth B., Brian Mitzman, Waseem Lutfi, et al.. (2018). Neoadjuvant Chemoradiation Shows No Survival Advantage to Chemotherapy Alone in Stage IIIA Patients. The Annals of Thoracic Surgery. 105(4). 1008–1016. 19 indexed citations
13.
Mitzman, Brian, et al.. (2017). Minimally Invasive Esophagectomy Provides Equivalent Survival to Open Esophagectomy: An Analysis of the National Cancer Database. Seminars in Thoracic and Cardiovascular Surgery. 29(2). 244–253. 36 indexed citations
14.
Ajmani, Gaurav S., et al.. (2017). Adjuvant radiation and survival following surgical resection of sinonasal melanoma. American Journal of Otolaryngology. 38(6). 663–667. 12 indexed citations
15.
Wang, Chi‐Hsiung, et al.. (2017). Preoperative adrenal biopsy does not affect overall survival in adrenocortical carcinoma. The American Journal of Surgery. 214(4). 748–751. 5 indexed citations
16.
Namm, Jukes P., Kiran H. Thakrar, Chi‐Hsiung Wang, et al.. (2017). A semi-automated assessment of sarcopenia using psoas area and density predicts outcomes after pancreaticoduodenectomy for pancreatic malignancy. Journal of Gastrointestinal Oncology. 8(6). 936–944. 29 indexed citations
17.
Yao, Katharine, Jeffrey Belkora, Isabelle Bedrosian, et al.. (2016). Impact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy: A Pilot Study. Annals of Surgical Oncology. 24(1). 91–99. 18 indexed citations
18.
Liederbach, Erik, et al.. (2015). Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base. Journal of the American College of Surgeons. 221(1). 187–196. 50 indexed citations
19.
Kantor, Olga, Catherine Pesce, Erik Liederbach, et al.. (2015). Surgery and hormone therapy trends in octogenarians with invasive breast cancer. The American Journal of Surgery. 211(3). 541–545. 17 indexed citations
20.
Yao, Katharine, Erik Liederbach, Catherine Pesce, Chi‐Hsiung Wang, & David J. Winchester. (2015). Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer. Journal of the American College of Surgeons. 221(1). 71–81. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026